Phaos Technology
Builds optical microscopy systems for inspection, metrology and biology.
Something off on this page? Send us feedback.
Profile
Builds advanced optical microscopes and bundled analysis software for industrial inspection, metrology, biology and research, earning primarily from device and parts sales with maintenance support. The Cayman-listed parent owns the Singapore operating subsidiary, while core microsphere technology is licensed from NUS.
Designs and assembles advanced optical microscopy systems, centered on the OptoNano super-resolution platform and the PT-Industrial, PT-Metrology, PT-Biology, PT-Stereo and PT-Zoom ranges. Proprietary software supports instrument control, automation, data analysis and pattern recognition, but is bundled with hardware rather than sold separately. Sales are chiefly device and parts shipments, supplemented by maintenance contracts, to manufacturers, biomedical providers and research institutions.
Reaches customers directly and through distributors and consultants across Asian markets, while providing customized end-to-end systems. Operations depend on third-party components, an OEM supplier, in-house assembly and licensed NUS microsphere technology. Revenue is concentrated in a small customer base and recognizes after delivery and customer acceptance.
Company facts
Key statistics
Year to date −94.7% · Average volume (30d) 252.5K
Analysts
No analyst consensus on record.
Earnings
Not reported.
Financial highlights
| 1 quarters | — | — | — | — | — | Q2 FY25 | |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $53.4K | |
| Gross profit | — | — | — | — | — | −$483.3K | |
| Operating income | — | — | — | — | — | −$941.5K | |
| Net income | — | — | — | — | — | −$917.8K | |
| Diluted EPS | — | — | — | — | — | −$0.03 | |
| Gross margin | — | — | — | — | — | -904.8% | |
| Operating margin | — | — | — | — | — | -1,762.5% |
Balance sheet, Oct 31, 2025Cash & short-term investments $33.2K · Total debt $2.4M · Total assets $793.5K · Shareholders' equity −$2.1M
Dividends
No dividends on record.
Ownership
Shares outstanding 13.71M · Float 12.41M · 90.5% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| XTX Topco Ltd | 153.1K | 1.12% | 13F | May 15, 2026 |
| HRT Financial LP | 119.2K | 0.87% | 13F | May 14, 2026 |
| UBS Group AG | 22.6K | 0.17% | 13F | May 5, 2026 |
| Renaissance Technologies LLC | 14.1K | 0.10% | 13F | May 14, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- Danaher
Leica systems overlap in industrial inspection and biological microscopy.
- Bruker
Super-resolution bioimaging alternative for research microscopes.
